Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. - Wikidata - awgldk - TriplyDB

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q33372195

about

Therapeutic interventions for Burkitt lymphoma in children Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma How I treat HIV-associated lymphoma Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium.Quality of life, characteristics and survival of patients with HIV and lymphoma.Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.Consensus statement on the use of rituximab in patients with rheumatoid arthritis AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.Hematopoietic stem cell transplantation for AIDS-related malignancies Modern management of non-Hodgkin lymphoma in HIV-infected patients.Rituximab therapy in malignant lymphoma.The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma.Immunotherapy for HIV-associated non-Hodgkin's lymphoma.Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.Cancer in cohort of HIV-infected population: prevalence and clinical characteristics.Therapeutic options for HIV-associated lymphomas.Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana.Infections associated with monoclonal antibody and fusion protein therapy in humans.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Clinical management of HIV-associated hematologic malignancies.Ongoing change in the treatment of HIV-associated malignancies in the HAART era.Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Rituximab in the treatment of non-Hodgkin's lymphoma Raltegravir-based HAART regimen in a patient with large B-cell lymphoma.A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.

P2860

Q24235495-8F9535DB-5EB8-467B-BF5A-486D1B92E251 Q24240190-110224A5-FA42-43E6-A840-40BE0798325D Q26821860-35492F82-5FE1-43A4-AD29-5E0833FDB9CC Q27691388-14E53098-8595-4AD9-9CBD-62F559A9CBA7 Q33401481-0E999379-A638-4256-8C2B-B5FEE646BB0C Q33629332-EE3A8405-6244-44A6-926F-7CDE15499FD2 Q33651611-FD6B562F-CBBA-4CB4-8AEF-5F2801304582 Q33767818-54FFC00F-1C00-4B91-8003-0067052590E1 Q33806007-63A9FA0E-0A86-4D74-9DA2-65A2F298E7DC Q33952616-4E122120-7B81-443A-8630-651E06953D5F Q34047901-FD2FAA77-133B-4F77-A7CF-063FA8932F85 Q35583973-8E1970CF-03AC-4B57-A9BA-838F88700F2B Q35606384-703BDB15-7955-4EFE-BAE5-D8518BB2F4AA Q35638676-EFAA1DCC-E97D-4C3F-8A80-BA18889D71FA Q35779619-7E9634AD-6634-44F7-B901-ADF08D0A0662 Q35848330-7E2A0F71-ABDC-46F1-8907-D9CCFC71D3E2 Q35850380-F09FF76D-E144-4F72-B080-A6E8FAF869EA Q36510026-EA48A456-3134-49E4-917A-0DE331033CF0 Q36710347-82B8AFE5-C2F8-4CB3-98BE-D747FCC7E312 Q36832102-9DA0B069-9CD0-4E8D-B916-4F443ED982B1 Q36956149-A273AD5F-265C-4661-A22A-F8710FDAF553 Q37106782-85533A50-93C0-48E3-9C3E-825AFF2EDCAF Q37291598-88C710D4-7CA5-4F84-B113-022C82374C4B Q37563265-9E21C3BA-1AFF-4904-8D29-8AAF030C83E8 Q37567836-B839E3F6-4DE4-4006-AB28-08E2F236000B Q37572815-F9EEC242-F13B-4B12-9E03-9B8F797A78BC Q37763574-8F589617-F3AB-4AE0-909A-4C29D5977CDC Q37781368-E2B6A3F9-DC03-4C6C-9DC3-02CF0B1FB380 Q37868477-A6847AEB-5749-4847-96FA-820DAD9D61DB Q37912944-18AEF2D5-0B9D-4F7D-A2F8-B3C446FA4141 Q38194845-264AE145-AE20-4C42-9FEF-89859BF63F10 Q38210131-EE06AE9B-C6B8-4C19-9EF5-1F1170042496 Q38664912-64E65BE9-D851-42CC-975C-052BB4356DCD Q39207881-F95650E0-9A29-40CE-8761-2649BEF76DB1 Q41678875-F3F8F9E7-0ACB-46F2-B0CB-82F0B028F3B8 Q41919568-9D30AA03-821B-4965-9835-64E431D2D322 Q41925899-04D9AF50-B122-462C-95DF-B914D2ACC687 Q43205348-F5C0FB3F-AFE3-48D3-A03D-E525178A5DC4 Q43752446-1E215D30-3F40-4345-84A5-E9718C938AEF Q47563526-22CFA9A1-019B-4768-88EE-864545105140

P2860

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q33372195

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@ast

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@en

type

label

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@ast

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@en

prefLabel

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@ast

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@en

P1433

Q33372195-1608D162-C5AB-4D24-A13D-96AED149CA76

P1476

Q33372195-F31966B6-3553-4715-B172-08BF40184F8F

P2093

Q33372195-1178B45B-1A69-42D7-A0A0-55CA45ED42C8

Q33372195-1184DA8D-8138-479D-8821-903930C862E8

Q33372195-2F9C5706-774E-49E9-B3D5-C2AC3D588D36

Q33372195-3EF82411-94D6-410B-A692-B47361323787

Q33372195-45D3E258-B0E4-4173-8658-6AC28A5993E6

Q33372195-6E15DBED-0D2C-44F0-9F50-8876991E45DA

Q33372195-92F65F5C-F97C-463E-B247-33448AFD7240

Q33372195-A3183C00-1EC0-4043-AAA9-C5EA2CD1F5A2

Q33372195-ED74A15C-97EA-40F3-9321-890AC4B2863D

P304

Q33372195-3E0B7D3E-5ED5-4AAF-94DF-78F4A35570B3

P31

Q33372195-5319A995-4C47-4E7C-B09F-1A209EBDB9F0

P356

Q33372195-DEB3AB68-167F-4A58-B3A0-E83125EF14E7

P407

Q33372195-5C4280F9-A031-452F-90B1-692312FE26B0

P433

Q33372195-CD71B7B6-F75B-482B-A50B-E7DDF755114A

P478

Q33372195-645C5A25-5F82-4EB7-81CE-F2FEEA24DEAD

P50

Q33372195-229EFED4-7BE3-4F2C-AF98-7E675EB81643

P577

Q33372195-C72A6C73-90DD-43D0-8016-7BF419002304

P698

Q33372195-5F878F05-BDAD-4303-9DD9-B34A74D2FD91

P921

Q33372195-3A5259AD-C780-4DE7-A5C6-B209AE36EDFC

P356

JCO.2005.05.4684

P1433

Journal of Clinical Oncology

P1476

Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.

@en

P2093

Antoine Cheret

http://www.w3.org/2001/XMLSchema#string

Christian Gisselbrecht

http://www.w3.org/2001/XMLSchema#string

Eric Billaud

http://www.w3.org/2001/XMLSchema#string

Fabrice Bonnet

http://www.w3.org/2001/XMLSchema#string

François Boué

http://www.w3.org/2001/XMLSchema#string

Jacques Reynes

http://www.w3.org/2001/XMLSchema#string

Jean Gabarre

http://www.w3.org/2001/XMLSchema#string

Martine Raphael

http://www.w3.org/2001/XMLSchema#string

Remi Lancar

http://www.w3.org/2001/XMLSchema#string

P304

4123-4128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.05.4684

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Costagliola

P577

2006-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16896005

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial